Smith & Nephew Inc. got a partial win in a dispute over its employees’ 401(k) plan, when a federal magistrate judge ...

The US Labor Department’s support of employers in the litigation wave targeting how they handle 401(k) plan forfeitures ...

In filing an amicus brief to an appeal involving HP Inc., the Department of Labor offered guidance on an issue that has ...

Since there have been more than 50 similar 401(k) forfeiture lawsuits filed recently, the Department of Labor has weighed in ...

"Given the infancy of these novel theories and a largely unsettled legal landscape, it is paramount for plan sponsors and ...

An employee benefit linked to financial stress is becoming more popular than 401 (k) By Susan Caminiti, CNBC • Published June 30, 2025 • Updated on June 30, 2025 at 1:17 pm ...

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » However, if you're contributing enough to max out your 401 ...

Two months after Bristol Myers Squibb fended off a lawsuit which accused the drugmaker of using illegal tactics to protect its monopoly on multiple myeloma medicine Pomalyst, BMS is back in court ...

Two months after BMS fended off a lawsuit which accused it of using anticompetitive tactics, it is back in court, facing a similar lawsuit from Cigna.

Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic versions of its blockbuster blood cancer drug Pomalyst off the market so it ...

Cigna (CI) sues Bristol Myers Squibb (BMY), over antitrust violations related to marketing of its multiple myeloma drug, Pomalyst. Read more here.

Healthcare giant Cigna (NYSE:CI) has filed a lawsuit against pharmaceutical company Bristol Myers Squibb (NYSE:BMY), accusing the drugmaker of engaging in anti-competitive practices to maintain a ...